INDWELRIS
Live / Applied — First extension granted (statement of use) (as of 20 Jan 2026)
What this means for you
Not registered yet, but its 02 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98531374
- Mark type
- Stylized text
- Filed
- 02 May 2024
- Published for opposition
- 11 Feb 2025
- Attorney of record
- Danielle Rivera
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders, digital ulcers, all of the foregoing excluding topical pharmaceutical preparations and pharmaceutical preparations for the prevention and treatment of ophthalmic diseases or disorders
- Class 010 — Medical apparatus: Medical apparatus for introducing pharmaceutical preparations into the human body; implantable medical device for introducing pharmaceutical preparations into the human body, all of the foregoing excluding medical apparatus and medical devices for use in the ophthalmic field
Owner
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
Prosecution history
- 21 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jan 2026 — SOU EXTENSION 1 GRANTED
- 20 Jan 2026 — SOU EXTENSION 1 FILED
- 20 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Sept 2025 — POST PUBLICATION AMENDMENT - ENTERED
- 21 Sept 2025 — ASSIGNED TO PETITION STAFF
- 20 Sept 2025 — POST PUBLICATION AMENDMENT - ENTERED
- 18 Sept 2025 — ASSIGNED TO PETITION STAFF
- 21 Aug 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 11 Aug 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 04 Aug 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 13 Mar 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 11 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Feb 2025 — PUBLISHED FOR OPPOSITION